FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Potassium Acetate Injection, USP
Status: Currently in Shortage
»Date first posted: 06/10/2019
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Exela Pharma Sciences, LLC (Revised 02/23/2021)

Company Contact Information:
828-758-5474

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Potassium Acetate Inj. 40mEq (2mEq/ml) 20mL (NDC 51754-2001-4) Available Please check with wholesaler for availability. Additional production underway. Direct shipment to hospitals at 200 vials max per week are available from Exela. Customer Service # 828-758-5474, then press #2 Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English